Intercos (BIT:ICOS) Stock Faces A Margin Proof Challenge At 24x P E

Intercos stock sits around €14.20 after a strong multi month run, yet the real story sits in the margins rather than the share chart. The beauty supplier just delivered its best ever quarterly adjusted EBITDA in Q2 with a 16.7% margin and trailing 12 month net profit margin at 5.5%. The market is reacting to a growth story. The earnings tell a more nuanced tale about profitability quality.

The key question now is whether investors are paying up for genuine margin progress or simply chasing recent share price strength. The rest of this report tackles that gap between emotion and earnings.

Is Intercos trading at a justifiable premium with a 24x P/E and a DCF value close to the current price, or is optimism running ahead of the numbers? Compare the market story with our valuation analysis for Intercos

H1 2026 Earnings Summary

• Revenue (H1 2026 vs H1 2025): €512.5m vs €524.9m (slight decline year on year)
• Net Income (H1 2026 vs H1 2025): €23.9m vs €16.5m (up about 45% year on year)
• Basic EPS (H2 2025 vs H1 2025, most recent disclosed): €0.3462 vs €0.1709 (roughly doubled across the two half year periods)
• Adjusted EBITDA Margin (Q2 2026 vs Q2 2025): 16.7% vs 15.9% (around 80 bps margin improvement, the best quarterly level for Intercos)

Prefer visual charts instead of picking through dense earnings tables and margin figures for Intercos? See the full picture of Intercos, with its valuation front and center in an easy-to-scan dashboard, in our company report for Intercos.

Intercos bull case hinges on margin and mix proof

Bulls argue Intercos is turning its beauty co development model into higher quality earnings, powered by premium Make up, Hair & Body recovery and better use of new capacity. Q2 and H1 give that view some support. Adjusted EBITDA margin reached 16.7% in Q2 and gross margin in H1 improved by about 36 bps, which points to early benefits from mix and productivity. Make up EBITDA rose 9% with margin up 180 bps, helped by Prestige clients, and value added sales grew mid single digit at constant FX. Hair & Body sales grew 27% in Q2 and 5% in H1, matching the claim that new categories can offset softer areas. Net income rose about one third and net debt declined to €122.7m with leverage at 0.80x, which shows better cash discipline alongside margin work.

Bear case focuses on fragile volumes and mix risk

The bear story is that Intercos relies too heavily on favourable mix and financial engineering while core volumes and Asia remain fragile. H1 trends partly support that concern. Net sales in H1 were €512m, slightly below last year, and value added sales were only flat to slightly up at constant FX. Skincare revenue fell in H1 by 9.5% and segment EBITDA dropped about 24% with 300 bps of margin contraction from fixed cost underabsorption. Asia declined 8% in H1 and 5% in Q2, with local Chinese clients under pressure, which challenges the high growth regional pillar. Hair & Body delivered strong top line growth yet EBITDA for the segment fell about 25% due to lower margin packaging and contract work, which confirms the risk that mix can dilute profitability even when revenue trends look healthy.

Compare whether that margin-focused bull story or the volume and mix bear worries are closer to what the street is pricing in right now. See the consensus price target analysis for Intercos

Stay Ahead With Simply Wall St

If the margin story around Intercos has your attention, register for free with Simply Wall St and add it to a Watchlist to track share price moves against fair value estimates and watch for a better entry point. Once you own Intercos or any other stock, use the Portfolio Command Center to cut through noise and focus on the key events and fundamental changes that matter most to your holdings. For a broader view on sentiment and fresh ideas, join the Community to see how other investors are thinking about opportunities and risks. This way you can spot potential catalysts and warning flags earlier and stay a step ahead of the market.

Seeking Alternatives Beyond Intercos Now

Some stocks are building quiet breakout momentum while others are already flying or dropping. Use fresh ideas before the crowd catches up and the data goes stale, and get in early.

• Spot cash rich businesses that still trade like afterthoughts when you scan our curated list of solid balance sheet and fundamentals stocks (422 results) for opportunities that might not stay overlooked for long.
• Ride potential momentum in future facing infrastructure by reviewing the focused set of 89 nuclear energy infrastructure stocks before these projects move from under the radar to the front page.
• Target companies turning intelligent automation into real revenue by checking the concentrated group of 35 robotics and automation stocks while the story is still forming and expectations remain grounded.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com